GASTRO-ENTEROPANCREATIC NEUROENDOCRINE TUMOR
Clinical trials for GASTRO-ENTEROPANCREATIC NEUROENDOCRINE TUMOR explained in plain language.
Never miss a new study
Get alerted when new GASTRO-ENTEROPANCREATIC NEUROENDOCRINE TUMOR trials appear
Sign up with your email to follow new studies for GASTRO-ENTEROPANCREATIC NEUROENDOCRINE TUMOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New shot aims to control rare cancer better than current options
Disease control OngoingThis study is comparing a new, long-acting injection called CAM2029 against standard treatments for people with advanced neuroendocrine tumors of the gut or pancreas. The main goal is to see if the new treatment can keep the cancer from growing for a longer period of time while b…
Matched conditions: GASTRO-ENTEROPANCREATIC NEUROENDOCRINE TUMOR
Phase: PHASE3 • Sponsor: Camurus AB • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC
-
Radiation drug trial aims to stall aggressive gut cancer
Disease control OngoingThis study tested whether a targeted radiation drug called Lutathera, combined with a hormone therapy, works better than high-dose hormone therapy alone to control the growth of advanced neuroendocrine tumors in the digestive system. It involved 226 patients with more aggressive …
Matched conditions: GASTRO-ENTEROPANCREATIC NEUROENDOCRINE TUMOR
Phase: PHASE3 • Sponsor: Advanced Accelerator Applications • Aim: Disease control
Last updated Mar 23, 2026 15:19 UTC
-
New pill targets rare, Hard-to-Treat cancers
Disease control OngoingThis study is testing an experimental oral drug called CVM-1118 for people with advanced neuroendocrine tumors that have stopped responding to standard treatments. The main goal is to see if the drug can slow or stop the cancer from growing. Researchers will also closely monitor …
Matched conditions: GASTRO-ENTEROPANCREATIC NEUROENDOCRINE TUMOR
Phase: PHASE2 • Sponsor: TaiRx, Inc. • Aim: Disease control
Last updated Mar 06, 2026 15:38 UTC